Neoolife is pioneering and leading the field of tissue-engineered Biomimetic Heart Valves (BMHV) with polymeric scaffolds enabling endogenous in-situ tissue regeneration.  Neoolife will replace mechanical and animal-derived tissue valves with tissue-engineered Biomimetic Heart Valves designed to have an extended duration without the need for blood-thinning drugs.  Neoolife tissue-engineered Biomimetic Heart Valves provide a technological solution to the clinicians’ demands of enlarging the pool of patients that can benefit from Transcatheter Heart Valve Therapy.